![Brian Blakey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Blakey
Corporate Officer/Principal chez
STEALTH BIOTHERAPEUTICS CORP
Profil
Brian D.
Blakey is currently the Chief Business Officer at Stealth BioTherapeutics Corp.
and Stealth BioTherapeutics, Inc. He previously worked as a Director at GSK Plc from 1998 to 2004, as Vice President-Marketing at AtheroGenics, Inc. from 2006 to 2010, and as Chief Operations & Strategy Officer at Ogilvy Commonhealth Market Access from 2010 to 2014.
He received a doctorate degree from the University of Florida in 1986.
Postes actifs de Brian Blakey
| Sociétés | Poste | Début |
|---|---|---|
| STEALTH BIOTHERAPEUTICS CORP | Corporate Officer/Principal | 01/02/2014 |
Stealth BioTherapeutics, Inc.
 Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat the mitochondrial dysfunctions and age-related diseases | Corporate Officer/Principal | 01/02/2014 |
Anciens postes connus de Brian Blakey
| Sociétés | Poste | Fin |
|---|---|---|
Ogilvy Commonhealth Market Access
 Ogilvy Commonhealth Market Access Advertising/Marketing ServicesCommercial Services Provides medical marketing services | Directeur des opérations | 01/02/2014 |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Corporate Officer/Principal | 01/05/2010 |
| GSK PLC | Directeur/Membre du Conseil | 01/02/2004 |
Formation de Brian Blakey
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
84
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ogilvy Commonhealth Market Access
Ogilvy Commonhealth Market Access Advertising/Marketing ServicesCommercial Services Provides medical marketing services | Commercial Services |
Stealth BioTherapeutics Corp.
 Stealth BioTherapeutics Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops investigational drugs for the treatment of diseases involving mitochondrial dysfunction | Health Technology |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat the mitochondrial dysfunctions and age-related diseases | Health Technology |
Choisissez Zonebourse 
